Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pre-miR-148a is a precursor microRNA molecule that serves as a template for the production of mature miR-148a. In glioblastoma research, it has been characterized as an oncogenic factor that enhances cell proliferation, migration, and invasion. Its mechanism involves the direct targeting and inhibition of MIG6 (ERRFI1), a negative regulator of the EGFR pathway, and BIM (BCL2L11), a pro-apoptotic protein. By suppressing these targets, pre-miR-148a facilitates constitutive EGFR activation and evades apoptosis, contributing to the malignancy of glioblastoma stem cells. It is primarily utilized as a research tool to investigate miRNA-mediated gene regulation and as a potential target for therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pre-miR-148a.